Join the DDW team at SLAS2024 in Boston

Boston, MA

The DDW team is looking forward to meeting you at SLAS2024, Boston, US on 3-7 February.

New for this year is the DDW track at the SLAS Ignite Theater, co-sponsored by Integra Biosciences and Hamamatsu Corporation. Industry experts will share their experiences of how drug discovery technology is driving innovation from bench to bedside. The track is free to attend but spaces are limited.

All the DDW team will be at the event: Maria Wallace, Managing Director, Lu Rahman, Publishing Director, Sarah Orme, Sales Director, Rich York, Account Director, Reece Armstrong, Editor, Megan Thomas, Multimedia Editor, and Diana Spencer, Digital Content Editor. Come to the Ignite Theater  / Booth 395 to pick up The Winter 2023/2024 copy of DDW. This includes an exclusive SLAS2024 supplement and a Therapeutic Antibody Guide.

Maria Wallace
Maria Wallace
Lu Rahman
Lu Rahman
Sarah Orme
Sarah Orme
Rich York
Rich York
Reece Armstrong
Reece Armstrong
Megan Thomas
Megan Thomas
Diana Spencer
Diana Spencer

The team will be happy to talk to you about upcoming publications and opportunities as well as outline DDW’s range of 2024 events. If you are interested in submitting content, speaking at an event or would like to know more about our commercial opportunities, please come and see a member of the team.

The DDW Ignite Theater programme will feature:

Monday 5 Feb:

  • 11am Dipanwita Das, CEO of Sorcero: ‘Is pharma’s commercial model dying?’
  • 3pm Andrea Bortolato, Director of Drug Discovery at SandboxAQ: ‘Combining physics-based methods with AI solutions to maximise the probability of success and speed of drug discovery and development’.
  • 3.30pm Simon Bushell, SVP of Molecular Discovery at Entact Bio: ‘Proximity-inducing drugs: Using technological innovation to build the next generation of medicine’.

Tuesday 6 Feb

  • 11am Masaru Kanekiyo, Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC), NIAID: ‘Structural vaccinology for influenza’.
  • 3pm Isaac Bentwich, Founder and CEO of Quris-AI: ‘How AI and patient-on-chip are improving drug discovery and development’.
  • 3.30pm Anubhav Tripathi, Professor of Medical Science and Engineering at Brown University: ‘Accelerating biotherapeutics development through technology platforms’.

Register now to show your interest in the Ignite Theater track.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free